Response from authors

1 Okin PM K Wachtell Devereux RB Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 2006; 296(10):1242–8.

2Mitchell GF,Vasan RS, Keyes MJ Pulse pressure and risk of new-onset atrial fibrillation. JAMA 2007; 297(7):709–15.

3 Lip GY L Frison Grind M; SPORTIF Investigators. Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur Heart J 2007; 28(6):752–9.

4 Healey JS A Baranchuk Crystal E Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005; 45(11):1832–9.

5 Wachtell K B Hornestam Lehto M Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005; 45(5):705–11.

6 Fitzmaurice DA FD Hobbs Jowett S Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007; 335(7616):383.

7 Mant J DA Fitzmaurice Hobbs FD Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. BMJ 2007; 335(7616):380.

8 Lip GY Tse HF. Management of atrial fibrillation. Lancet 2007; 370(9587):604–18.

9 Lip GY Lim HS. Atrial fibrillation and stroke prevention. Lancet Neurol 2007; 6(11):981–93.